Correlation Between Senti Biosciences and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Neoleukin Therapeutics, you can compare the effects of market volatilities on Senti Biosciences and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Neoleukin Therapeutics.
Diversification Opportunities for Senti Biosciences and Neoleukin Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Senti and Neoleukin is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Senti Biosciences and Neoleukin Therapeutics
Given the investment horizon of 90 days Senti Biosciences is expected to under-perform the Neoleukin Therapeutics. In addition to that, Senti Biosciences is 1.51 times more volatile than Neoleukin Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Neoleukin Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 47.00 in Neoleukin Therapeutics on August 23, 2024 and sell it today you would earn a total of 22.00 from holding Neoleukin Therapeutics or generate 46.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 32.26% |
| Values | Daily Returns |
Senti Biosciences vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Senti Biosciences |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Senti Biosciences and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Neoleukin Therapeutics
The main advantage of trading using opposite Senti Biosciences and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |